| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accuracy of metabolomics profiles to non-invasively diagnose NAFLD stages and evolution by mean of machine-learning automated algorithms
|
Masarone, M.
|
|
|
52 |
S1 |
p. e9
|
artikel
|
| 2 |
A cholestatic pattern predicts liver outcomes in patients with nonalcoholic fatty liver disease
|
Pennisi, G.
|
|
|
52 |
S1 |
p. e40
|
artikel
|
| 3 |
Acute kidney injury is associated with reversible platelet dysfunction in hospitalized patients with decompensated cirrhosis
|
Zanetto, A.
|
|
|
52 |
S1 |
p. e13
|
artikel
|
| 4 |
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group
|
D’Amato, D.
|
|
|
52 |
S1 |
p. e32
|
artikel
|
| 5 |
Adherence to Surviving Sepsis campaign 3-hour bundles improves survival in non-critically ill patients with cirrhosis and sepsis
|
Piano, S.
|
|
|
52 |
S1 |
p. e12-e13
|
artikel
|
| 6 |
Adipopenia, among the nutritional parameters, is the one that best correlates with mortality in decompensated cirrhotic patients: results of a prospective study
|
De Luca, M.
|
|
|
52 |
S1 |
p. e61
|
artikel
|
| 7 |
A genetic risk score predicts de novo hepatocellular carcinoma in hepatits c cirrhotic patients treated with direct-acting antivirals
|
Degasperi, E.
|
|
|
52 |
S1 |
p. e19
|
artikel
|
| 8 |
A higher dietary intake of phenolic acids is protective against insulin resistance and non-alcoholic fatty liver disease
|
Salomone, F.
|
|
|
52 |
S1 |
p. e41
|
artikel
|
| 9 |
A.I.S.F. 2020
|
|
|
|
52 |
S1 |
p. e72
|
artikel
|
| 10 |
A multidisciplinary approach to non-alcoholic fatty liver disease (NAFLD) improves cardiovascular risk factors: the experience of a tertiary liver center in UK
|
Mantovani, A.
|
|
|
52 |
S1 |
p. e46
|
artikel
|
| 11 |
Analysis of resistance and phylogenetic clusters in HCV-2c infected patients within the Italian network Vironet C
|
Barbaliscia, S.
|
|
|
52 |
S1 |
p. e24-e25
|
artikel
|
| 12 |
An immunohistochemical study on lymphoid T-cell subsets and activation state in hepatocellular carcinoma
|
Vasuri, F.
|
|
|
52 |
S1 |
p. e52
|
artikel
|
| 13 |
A novel HER2-targeted liposomal formulation reduces the risk of hepatotoxicity induced by PEG-based anticancer drugs
|
De Martin, S.
|
|
|
52 |
S1 |
p. e30-e31
|
artikel
|
| 14 |
A novel nomogram based on liver stiffness to predict the comprehensive complication index after liver resection in patients with hepatocellular carcinoma
|
Serenari, M.
|
|
|
52 |
S1 |
p. e17
|
artikel
|
| 15 |
Antioxidant and anti-inflammatory effect of oleuropein in hepatic steatosis
|
Santini, S.J.
|
|
|
52 |
S1 |
p. e32
|
artikel
|
| 16 |
Application of BCLC-B subclassification and Hong Kong Liver Cancer Systems to intermediate stage hepatocellular carcinoma
|
Ricco, G.
|
|
|
52 |
S1 |
p. e54
|
artikel
|
| 17 |
Autoantibody study in Primary Biliary Cholangitis and possible relation with therapeutic response
|
Cacciato, V.
|
|
|
52 |
S1 |
p. e31
|
artikel
|
| 18 |
Care or palliation for recurrent hepatocarcinoma: a multicentric national analysis of survival
|
Famularo, S.
|
|
|
52 |
S1 |
p. e47-e48
|
artikel
|
| 19 |
Changes in bone mineral density during monotherapy with tenofovir disoproxil fumarate: a 6-year real life longitudinal cohort study in chronic hepatitis B caucasian patients
|
Viganò, M.
|
|
|
52 |
S1 |
p. e27
|
artikel
|
| 20 |
Circulating microRNA-21 and microRNA-122: prognosis prediction and correlation with HIF-1alpha in hepatocellular carcinoma patients treated with transarterial chemoembolization
|
Pelizzaro, F.
|
|
|
52 |
S1 |
p. e55
|
artikel
|
| 21 |
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC
|
Salvi, A.
|
|
|
52 |
S1 |
p. e56
|
artikel
|
| 22 |
Cold ischemic injury is reduced by the mGluR5 negative allosteric modulator MPEP in rat livers from cardiac death donors
|
Berardo, C.
|
|
|
52 |
S1 |
p. e66
|
artikel
|
| 23 |
Comparison of prognostic models in predicting survival of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: a multicenter cohort study
|
Marasco, G.
|
|
|
52 |
S1 |
p. e50
|
artikel
|
| 24 |
Comprehensive characterization of HBV in tumor and non-tumor liver tissues from patients with HBV related-HCC
|
Giosa, D.
|
|
|
52 |
S1 |
p. e3-e4
|
artikel
|
| 25 |
Cost of Illness of Primary Biliary Cholangitis in Lombardia
|
Gerussi, A.
|
|
|
52 |
S1 |
p. e36
|
artikel
|
| 26 |
C-THRU: Tracking of HCV patients lost to follow up-a Retrospective database review study
|
Cartabellotta, F.
|
|
|
52 |
S1 |
p. e21
|
artikel
|
| 27 |
Diabetes and DAAs
|
Dalbeni, A.
|
|
|
52 |
S1 |
p. e23
|
artikel
|
| 28 |
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection
|
Ferrarese, A.
|
|
|
52 |
S1 |
p. e15-e16
|
artikel
|
| 29 |
Directly acting antivirals are safe and effective in HCV elderly patients: a multicenter real life study
|
Pugliese, N.
|
|
|
52 |
S1 |
p. e28
|
artikel
|
| 30 |
Durable response in the markers of cholestasis through 5 years of open-label extension study of obeticholic acid in primary biliary cholangitis
|
Nevens, F.
|
|
|
52 |
S1 |
p. e30
|
artikel
|
| 31 |
Early liver transplantation in active drinkers with and without alcoholic hepatitis: a monocentric case series
|
Angrisani, D.
|
|
|
52 |
S1 |
p. e68-e69
|
artikel
|
| 32 |
Early recurrence of hepatocellular carcinoma after liver transplantation can be predicted by fdg-pet and microvascular invasion at explant pathology
|
Iavarone, M.
|
|
|
52 |
S1 |
p. e69-e70
|
artikel
|
| 33 |
Editorial Board
|
|
|
|
52 |
S1 |
p. i-ii
|
artikel
|
| 34 |
Effective albumin concentration and albumin function improve after long-term albumin therapy in patients with decompensated cirrhosis
|
Baldassarre, M.
|
|
|
52 |
S1 |
p. e14
|
artikel
|
| 35 |
Efficacy of transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome – chronic kidney disease
|
Ponzo, P.
|
|
|
52 |
S1 |
p. e59
|
artikel
|
| 36 |
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with mild-moderate fibrosis, with or without glucose abnormalities: interim results of the EGG18 study
|
Calvaruso, V.
|
|
|
52 |
S1 |
p. e26-e27
|
artikel
|
| 37 |
Epidemiological trends of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease in Italy
|
Farinati, F.
|
|
|
52 |
S1 |
p. e49
|
artikel
|
| 38 |
Epidemiology, features and outcomes of patients transplanted for hepatocellular carcinoma in the last decade: a single center experience
|
Invernizzi, F.
|
|
|
52 |
S1 |
p. e70
|
artikel
|
| 39 |
ESBLE and MRSA carriage in cirrhotic patients: a retrospective study on clinical outcomes before and after liver transplantation
|
Magro, B.
|
|
|
52 |
S1 |
p. e67
|
artikel
|
| 40 |
Factor VIII/Protein C and not ADAMTS13/VWF:Ag ratio is a prognostic risk factor for patients with cirrhosis and low MELD score
|
Bitto, N.
|
|
|
52 |
S1 |
p. e13-e14
|
artikel
|
| 41 |
Fatty acids regulate the biology of cholangiocarcinoma cells
|
Lori, G.
|
|
|
52 |
S1 |
p. e50
|
artikel
|
| 42 |
Frequency of TP53, CTNNB1, and TERT promoter mutations in patients with hepatocellular carcinoma
|
Lombardo, D.
|
|
|
52 |
S1 |
p. e52-e53
|
artikel
|
| 43 |
Ganglioside patterns in the human cholangiocarcinoma stem cell subset A
|
Mannini, A.
|
|
|
52 |
S1 |
p. e11
|
artikel
|
| 44 |
Genetic and B-cell clonality markers in HCV-related cryoglobulinemic vasculitis persisting after DAA therapy
|
Marri, S.
|
|
|
52 |
S1 |
p. e1
|
artikel
|
| 45 |
Genetic variants do not predict the development of hepatocellular carcinoma in cross-sectional and longitudinal studies including caucasian compensated hbv cirrhotics treated with nuc for 10 years
|
Galmozzi, E.
|
|
|
52 |
S1 |
p. e25
|
artikel
|
| 46 |
Global characterization of tumor infiltrate of Intrahepatic Cholangiocarcinoma by single cell sequencing
|
Soldani, C.
|
|
|
52 |
S1 |
p. e48-e49
|
artikel
|
| 47 |
HBsAg clearance in HBeAg negative infection and treated chronic hepatitis B is associated with different HBsAg kinetics
|
Colombatto, P.
|
|
|
52 |
S1 |
p. e27-e28
|
artikel
|
| 48 |
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression
|
Turato, C.
|
|
|
52 |
S1 |
p. e65-e66
|
artikel
|
| 49 |
Hepatocyte-specific deletion of ERK5 worsens insulin resistance in a murine model of nonalcoholic fatty liver disease (NAFLD)
|
Di Maira, G.
|
|
|
52 |
S1 |
p. e37
|
artikel
|
| 50 |
High rate of misclassification of fibrosis stage using Transient Elastography in patients with Primary Biliary Cholangitis
|
Rossi, M.
|
|
|
52 |
S1 |
p. e34
|
artikel
|
| 51 |
Histological renal damage and eligibility for kidney donation are worse in patients with biopsy-proven non-alcoholic steatohepatitis compared with simple steatosis
|
Mulazzani, L.
|
|
|
52 |
S1 |
p. e39
|
artikel
|
| 52 |
Impact of direct-acting antivirals in the management of post-liver transplant recipients compared with the interferon-era
|
Martini, S.
|
|
|
52 |
S1 |
p. e69
|
artikel
|
| 53 |
Impact of HBV infection in HCV/HBV coinfected patients treated with DAAs IN Northern Italy
|
Fabris, P.
|
|
|
52 |
S1 |
p. e19-e20
|
artikel
|
| 54 |
Infection in cirrhosis: a changing epidemiologic setting
|
Pellone, M.
|
|
|
52 |
S1 |
p. e64
|
artikel
|
| 55 |
Inhibiting NOXs with extra-virgin olive oil polyphenols as a strategy to prevent hepatic fibrogenesis
|
Gabbia, D.
|
|
|
52 |
S1 |
p. e65
|
artikel
|
| 56 |
Inhibition of isoform D of phosphodiesterase type 4 reduces cell proliferation and survival in hepatocarcinoma cell lines
|
Ragusa, F.
|
|
|
52 |
S1 |
p. e49
|
artikel
|
| 57 |
Interplay between metabolic derangement, hepatic fibrogenesis and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease
|
Rosso, C.
|
|
|
52 |
S1 |
p. e10
|
artikel
|
| 58 |
Liver steatosis detected by controlled attenuation parameter (CAP) increases after HCV eradication with direct-acting antiviral therapy: preliminary data
|
Cespiati, A.
|
|
|
52 |
S1 |
p. e26
|
artikel
|
| 59 |
Liver stiffness measurement by fibroscan predicts the occurrence of liver-related events and death in patients with NAFLD-related compensated advanced chronic liver disease
|
Petta, S.
|
|
|
52 |
S1 |
p. e40-e41
|
artikel
|
| 60 |
Liver transplantation in patients with ACLF. Preliminary experience of 6 Italian centres
|
Perricone, G.
|
|
|
52 |
S1 |
p. e17-e18
|
artikel
|
| 61 |
Long-term albumin therapy is not futile in patients with cirrhosis and uncomplicated ascites not normalizing on-treatment serum albumin concentration
|
Tufoni, M.
|
|
|
52 |
S1 |
p. e57-e58
|
artikel
|
| 62 |
Long-term liver fibrosis and outcomes in HCV-infected solid organ transplant recipients after DAAs-induced viral eradication
|
Manuli, C.
|
|
|
52 |
S1 |
p. e22
|
artikel
|
| 63 |
Long-term prospective study of development of hepatocellular carcinoma in compensated cirrhosis
|
Pivetti, A.
|
|
|
52 |
S1 |
p. e61
|
artikel
|
| 64 |
Long term renal safety of HCV direct acting antivirals in HCV positive kidney transplant recipients
|
Rendina, M.
|
|
|
52 |
S1 |
p. e22
|
artikel
|
| 65 |
Metabolic and functional recovery of tumor infiltrating NK-cells in Hepatocellular Carcinoma
|
Zecca, A.
|
|
|
52 |
S1 |
p. e12
|
artikel
|
| 66 |
Microelimination of HCV in residual populations of coinfected HIV/HCV: real-life data from an hospital setting in Southern Italy
|
Fusco, F.M.
|
|
|
52 |
S1 |
p. e25
|
artikel
|
| 67 |
Mitochondrial oxidative metabolism contributes to maintain a cancer stem cell phenotype in cholangiocarcinoma
|
Raggi, C.
|
|
|
52 |
S1 |
p. e47
|
artikel
|
| 68 |
Moderate alcohol consumption is associated with risk of fibrosis in patients with non-alcoholic fatty liver disease
|
Mulazzani, L.
|
|
|
52 |
S1 |
p. e43-e44
|
artikel
|
| 69 |
Myeloid cell-specific deficiency of ERK5 regulates the response to liver regeneration after partial hepatectomy (PH) in mice
|
Di Maira, G.
|
|
|
52 |
S1 |
p. e58
|
artikel
|
| 70 |
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients
|
Lombardi, R.
|
|
|
52 |
S1 |
p. e45
|
artikel
|
| 71 |
Nailfold capillaroscopy: a useful instrument for early diagnosis of systemic sclerosis in patients with primary biliary cholangitis
|
Crescenzi, D.
|
|
|
52 |
S1 |
p. e29
|
artikel
|
| 72 |
Neoangiogenic transcriptomic signature identifies HCCs with worse response to treatment: long-term results of a prospective study
|
Pivetti, A.
|
|
|
52 |
S1 |
p. e11-e12
|
artikel
|
| 73 |
New and old therapy against Carbapenemase-Producing Klebsiella pneumoniae (kpc) infections in the cirrhotic patient: a retrospective analysis
|
Di Cola, S.
|
|
|
52 |
S1 |
p. e36
|
artikel
|
| 74 |
Noninvasive risk stratification in nonalcoholic fatty liver disease: a polygenic risk score
|
Bianco, C.
|
|
|
52 |
S1 |
p. e9-e10
|
artikel
|
| 75 |
Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 Regenerate study
|
Anstee, Q.M.
|
|
|
52 |
S1 |
p. e41-e42
|
artikel
|
| 76 |
Obeticholic Acid Treatment in Patients with Non-Alcoholic Steatohepatitis: A Secondary Analysis of the Regenerate Study Across Fibrosis Stages
|
Sanyal, A.J.
|
|
|
52 |
S1 |
p. e46-e47
|
artikel
|
| 77 |
Oncostatin M, a novel profibrogenic mediator, is involved in the progression non-alcoholic fatty liver disease and stimulates migration of myofibroblasts
|
Foglia, B.
|
|
|
52 |
S1 |
p. e14-e15
|
artikel
|
| 78 |
Overall Health, Daily Functioning, and Quality of Life in Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
|
Sardh, E.
|
|
|
52 |
S1 |
p. e35
|
artikel
|
| 79 |
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with non-alcoholic fatty liver
|
Grimaudo, S.
|
|
|
52 |
S1 |
p. e8
|
artikel
|
| 80 |
Perception of illness in Italian patients with Primary Biliary Cholangitis referred to tertiary care units
|
Cazzagon, N.
|
|
|
52 |
S1 |
p. e6
|
artikel
|
| 81 |
Personalized platelets/liver stiffness ratio improves and secures the screening of esophageal varices needing treatment
|
Berger,
|
|
|
52 |
S1 |
p. e57
|
artikel
|
| 82 |
PIVKA_II a useful biomarker for hepatocellular carcinoma in caucasian HCV cirrhotic patients treated with direct-acting antivirals
|
Degasperi, E.
|
|
|
52 |
S1 |
p. e10-e11
|
artikel
|
| 83 |
PNPLA3 rs738409 C>G variant is associated with a higher risk of liver fibrosis progression assessed by FIB-4 and stiffness by fibroscan in patients with non-alcoholic fatty liver disease
|
Grimaudo, S.
|
|
|
52 |
S1 |
p. e38-e39
|
artikel
|
| 84 |
Pre-existing liver disease and severity of DILI in an Italian cohort
|
Minissale, M.G.
|
|
|
52 |
S1 |
p. e6
|
artikel
|
| 85 |
Primary biliary cholangitis: histological and clinical liver progression in non responders to ursodeoxycholic acid
|
Cacciato, V.
|
|
|
52 |
S1 |
p. e35-e36
|
artikel
|
| 86 |
Procoagulant imbalance in patients with non-cirrhotic Chronic hepatitis C (CHC) improves six months after eradication with direct-acting antiviral agents (DAAs) and likely correlates with liver fibrosis
|
Sigon, G.
|
|
|
52 |
S1 |
p. e1-e2
|
artikel
|
| 87 |
Prognostic and diagnostic role of VEGF-A and HIF-1α in hepatocellular carcinoma treated with chemoembolization
|
Peserico, G.
|
|
|
52 |
S1 |
p. e53
|
artikel
|
| 88 |
Prognostication of hepatocellular carcinoma under sorafenib: external validation of the PROSASH-II model
|
Sansone, V.
|
|
|
52 |
S1 |
p. e15
|
artikel
|
| 89 |
Quantitative HBeAg varies across the different phases of HBV infection, and can predict treatment outcome in the setting of HBV-reactivation driven by iatrogenic immunosuppression
|
Piermatteo, L.
|
|
|
52 |
S1 |
p. e21-e22
|
artikel
|
| 90 |
Real-world data on the treatment of primary biliary cholangitis with obeticholic acid in Italy: the CLEO-AIGO OCA cohort
|
Vespasiani-Gentilucci, U.
|
|
|
52 |
S1 |
p. e33
|
artikel
|
| 91 |
Recent trends and intention-to-treat survival of liver transplantation for nonalcoholic steatohepatitis: an Italian liver transplant registry study
|
Vitale, A.
|
|
|
52 |
S1 |
p. e16-e17
|
artikel
|
| 92 |
RECK- and TIMP-mediated downregulation of matrix metalloproteinase activity by obeticholic acid in hepatic ischemia/reperfusion
|
Di Pasqua, L.G.
|
|
|
52 |
S1 |
p. e63
|
artikel
|
| 93 |
Regulation of the biology of cholangiocarcinoma (CCA) cells by Extracellular-signal-regulated kinase 5 (ERK5)
|
Gentilini, A.
|
|
|
52 |
S1 |
p. e51
|
artikel
|
| 94 |
Retreatment with glecaprevir/pibrentasvir and sofosbuvir in patients with viral failure at DAA
|
Spinetti, A.
|
|
|
52 |
S1 |
p. e26
|
artikel
|
| 95 |
Risk factors for disease progression in non – cirrhotic patients with Primary Biliary Cholangitis
|
Rossi, M.
|
|
|
52 |
S1 |
p. e31
|
artikel
|
| 96 |
Risk factors for significant fibrosis differently affect patients with non-alcoholic liver disease depending on gender
|
Mulazzani, L.
|
|
|
52 |
S1 |
p. e44
|
artikel
|
| 97 |
Risk of contrast-induced acute kidney injury in cirrhotic patients undergoing computed tomography: myth or reality?
|
Campion, D.
|
|
|
52 |
S1 |
p. e64
|
artikel
|
| 98 |
Risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis of viral etiology evaluated by the association of alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-II (PIVKA-II) and glypican-3 (GPC-3)
|
Caviglia, G.P.
|
|
|
52 |
S1 |
p. e54
|
artikel
|
| 99 |
Role of a dedicated referral system for patients with liver disease and potential indication for liver transplantation: prospective data from a single centre experience
|
Germani, G.
|
|
|
52 |
S1 |
p. e70-e71
|
artikel
|
| 100 |
Role of cellular senescence in the natural history of primary sclerosing cholangitis
|
Sarcognato, S.
|
|
|
52 |
S1 |
p. e5-e6
|
artikel
|
| 101 |
Safety and efficacy of up to 76 weeks 10mg/day (high dose) bulevirtide monotherapy in compensated cirrhotics with delta hepatitis
|
Loglio, A.
|
|
|
52 |
S1 |
p. e28-e29
|
artikel
|
| 102 |
Sarco-model, a novel score to better predict the risk of death in cirrhotic patients awaiting liver transplantation
|
Lai, Q.
|
|
|
52 |
S1 |
p. e16
|
artikel
|
| 103 |
Sarcopenia correlates with mortality in cirrhotic patients who undergo transjugular intrahepatic portosystemic shunt creation for refractory ascites
|
Petridis, I.
|
|
|
52 |
S1 |
p. e62
|
artikel
|
| 104 |
Sarcopenia in liver transplant candidates
|
Mazzarelli, C.
|
|
|
52 |
S1 |
p. e66
|
artikel
|
| 105 |
Sarcopenia is common in patients with cirrhosis and unresectable HCC treated by transarterial embolization but is not associated with increased rates of complications
|
Masetti, C.
|
|
|
52 |
S1 |
p. e55
|
artikel
|
| 106 |
SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differences
|
Pelizzaro, F.
|
|
|
52 |
S1 |
p. e56
|
artikel
|
| 107 |
Selective LXR α intestinal activation reduces hepatic inflammation and fibrosis during the development of chronic liver injury
|
Gurrado, F.
|
|
|
52 |
S1 |
p. e42
|
artikel
|
| 108 |
SerpinB3 inhibition as a novel target therapy for non-alcoholic steatohepatitis
|
Martini, A.
|
|
|
52 |
S1 |
p. e39-e40
|
artikel
|
| 109 |
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on alkaline phosphatase
|
Gerussi, A.
|
|
|
52 |
S1 |
p. e4-e5
|
artikel
|
| 110 |
Spleen stiffness measurement predicts the development of primary hepatocellular carcinoma better than hepatic venous pressure gradient
|
Marasco, G.
|
|
|
52 |
S1 |
p. e50-e51
|
artikel
|
| 111 |
Spleen Stiffness/Platelets-Based Models Can Predict Presence of Esophageal Varices in Patients With Compensated Liver Cirrhosis
|
Giuffrè, M.
|
|
|
52 |
S1 |
p. e61-e62
|
artikel
|
| 112 |
Subtle changes of c-reactive protein and serum creatinine during the index hospitalization predict early readmission in patients with decompensated cirrhosis
|
Tufoni, M.
|
|
|
52 |
S1 |
p. e59
|
artikel
|
| 113 |
Terlipressin vs noradrenaline for the treatment of hepatorenal syndrome in patients with acute-on-chronic liver failure: a 5-year retrospective analysis
|
Giovo, I.
|
|
|
52 |
S1 |
p. e59-e60
|
artikel
|
| 114 |
The anti-inflammatory effects of hydroxytyrosol and vitamin e on paediatric NAFLD
|
Mosca, A.
|
|
|
52 |
S1 |
p. e42-e43
|
artikel
|
| 115 |
THE “CASERTA MODEL”. AN HCV WAY OUT IN PERSONS WHO USE DRUGS (PWUD) IN ITALY
|
Messina, V.
|
|
|
52 |
S1 |
p. e28
|
artikel
|
| 116 |
The combined usage of accurate virological and serological HBV markers can help to identify HBsAg-negative/anti-HBc-positive patients at higher risk of HBV-reactivation and to optimize prophylaxis duration in oncohematological setting
|
Salpini, R.
|
|
|
52 |
S1 |
p. e23
|
artikel
|
| 117 |
The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countries
|
Newsome, P.
|
|
|
52 |
S1 |
p. e33-e34
|
artikel
|
| 118 |
The HSD17B13 rs6834314 variant is associated with liver stiffness measurement in untreated HCV-3 patients with cirrhosis
|
Galmozzi, E.
|
|
|
52 |
S1 |
p. e20-e21
|
artikel
|
| 119 |
The impact of age in mortality and complications development in cirrhotic outpatients
|
Tonon, M.
|
|
|
52 |
S1 |
p. e65
|
artikel
|
| 120 |
The metabolic plasticity of neoplastic cholangiocytes: perspective for target therapy of intrahepatic cholangiocarcinoma
|
Polidoro, M.
|
|
|
52 |
S1 |
p. e5
|
artikel
|
| 121 |
The Piedmont-Aosta Valley Oncology Network experience in locally advanced HCC with intrahepatic neoplastic portal vein thrombosis: Y90-radioembolization versus Sorafenib
|
Martelletti, C.
|
|
|
52 |
S1 |
p. e53
|
artikel
|
| 122 |
The prevalence of esophageal varices needing treatment depends on gender, etiology and BMI
|
Ravaioli, F.
|
|
|
52 |
S1 |
p. e60
|
artikel
|
| 123 |
The PSRC1 rs599839 A>G variant disentangles the risk of coronary artery disease and hepatocellular carcinoma in Italian NAFLD patients
|
Meroni, M.
|
|
|
52 |
S1 |
p. e37
|
artikel
|
| 124 |
Therapy with DAA increases post-OLT survival but not the risk of recurrence in patients undergoing liver transplantation for HCV-related HCC
|
Sansone, V.
|
|
|
52 |
S1 |
p. e68
|
artikel
|
| 125 |
The role of postoperative ascites In determining long term survival after curative surgery for hepatocarcinoma: a national multicentric study
|
Famularo, S.
|
|
|
52 |
S1 |
p. e67-e68
|
artikel
|
| 126 |
The volume of enhancement of disease (VED) predicts the early response to treatment and overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib
|
Campani, C.
|
|
|
52 |
S1 |
p. e51-e52
|
artikel
|
| 127 |
The weight of pre-existing cofactors for liver disease progression in patients who successfully eradicated HCV virus infection: An interim analysis in the PITER cohort
|
Kondili, L.A.
|
|
|
52 |
S1 |
p. e7
|
artikel
|
| 128 |
TM6SF2/PNPLA3/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models
|
Longo, M.
|
|
|
52 |
S1 |
p. e7-e8
|
artikel
|
| 129 |
Transjugular intrahepatic portosystemic shunt is an effective and safe treatment of cirrhotic patients with portal vein thrombosis or cavernoma
|
De Nicola, S.
|
|
|
52 |
S1 |
p. e63
|
artikel
|
| 130 |
Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results
|
Lucas, K.J.
|
|
|
52 |
S1 |
p. e38
|
artikel
|
| 131 |
Validation of Interleukin-32 as a new circulating fatty liver biomarker
|
Baselli, G.A.
|
|
|
52 |
S1 |
p. e43
|
artikel
|
| 132 |
VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen
|
Di Maio, V.C.
|
|
|
52 |
S1 |
p. e2-e3
|
artikel
|
Tijdschrift beschrijving